REGN Insider Transactions — Page 27
4,472 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 2,601–2,700; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 15,274.0 | $538.31 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 20,730.0 | $537.21 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 23,423.0 | $536.26 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 19,042.0 | $535.22 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 12,828.0 | $534.42 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 5,945.0 | $533.23 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 2,544.0 | $531.93 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 6,043.0 | $530.68 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 8,689.0 | $530.1 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 4,694.0 | $529.04 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 2,573.0 | $527.85 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 3,472.0 | $526.9 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 1,200.0 | $525.88 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 3,211.0 | $524.45 |
| Sanofi | TenPercentOwner | 2015-09-23 | Purchase | 2,600.0 | $523.43 |
| BROWN MICHAEL S | Director | 2015-09-21 | Sale | 3,000.0 | $551.55 |
| BAKER CHARLES A | Director | 2015-09-17 | Sale | 5,000.0 | $550.0 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 1,500.0 | $578.63 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 2,258.0 | $577.75 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 2,004.0 | $576.65 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 700.0 | $575.47 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 900.0 | $574.75 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 2,717.0 | $573.64 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 2,800.0 | $572.6 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 5,598.0 | $571.54 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 3,603.0 | $570.63 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | Sale | 1,405.0 | $569.63 |
| POON CHRISTINE A | Director | 2015-08-12 | Sale | 12.0 | $564.17 |
| POON CHRISTINE A | Director | 2015-08-12 | Sale | 100.0 | $564.16 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 62.0 | $593.0 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 138.0 | $592.53 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 200.0 | $591.39 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 900.0 | $590.37 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 400.0 | $589.73 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 400.0 | $588.33 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 400.0 | $587.55 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 200.0 | $586.49 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 800.0 | $585.35 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 800.0 | $584.52 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 400.0 | $583.43 |
| GILMAN ALFRED G | Director | 2015-08-06 | Sale | 300.0 | $582.15 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 800.0 | $593.66 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 23.0 | $592.4 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 957.0 | $591.75 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 2,486.0 | $590.57 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 2,542.0 | $589.76 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 2,126.0 | $588.55 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 2,482.0 | $587.35 |
| Terifay Robert J | SVP Commercial | 2015-08-06 | Sale | 2,007.0 | $585.22 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-08-06 | Sale | 1,128.0 | $586.24 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-08-06 | Sale | 900.0 | $585.02 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-08-06 | Sale | 1,000.0 | $583.89 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-08-06 | Sale | 1,000.0 | $582.12 |
| Landry Robert E | SVP Finance & CFO | 2015-08-05 | Sale | 2,100.0 | $593.38 |
| Landry Robert E | SVP Finance & CFO | 2015-08-05 | Sale | 1,500.0 | $592.36 |
| Landry Robert E | SVP Finance & CFO | 2015-08-05 | Sale | 400.0 | $591.78 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-08-05 | Sale | 4,800.0 | $585.51 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-08-05 | Sale | 200.0 | $586.0 |
| Tessier-Lavigne Marc | Director | 2015-08-05 | Sale | 500.0 | $595.44 |
| Tessier-Lavigne Marc | Director | 2015-08-05 | Sale | 2,000.0 | $593.64 |
| Tessier-Lavigne Marc | Director | 2015-08-05 | Sale | 1,000.0 | $590.17 |
| Tessier-Lavigne Marc | Director | 2015-08-05 | Sale | 1,500.0 | $584.07 |
| GOLDSTEIN JOSEPH L | Director | 2015-08-04 | Sale | 2,000.0 | $586.0 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 253.0 | $542.28 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 700.0 | $541.15 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 2,503.0 | $540.2 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 1,600.0 | $539.22 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 948.0 | $537.86 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 1,633.0 | $537.1 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 305.0 | $535.71 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 700.0 | $534.34 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 823.0 | $533.19 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 674.0 | $532.36 |
| Sanofi | TenPercentOwner | 2015-07-27 | Purchase | 500.0 | $530.71 |
| GOLDSTEIN JOSEPH L | Director | 2015-07-15 | Sale | 2,000.0 | $550.0 |
| GOLDSTEIN JOSEPH L | Director | 2015-06-22 | Sale | 2,000.0 | $526.85 |
| SING GEORGE L | Director | 2015-05-27 | Sale | 5,000.0 | $515.0 |
| INGRAM ROBERT ALEXANDER | Director | 2015-05-27 | Sale | 1,379.0 | $513.39 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-05-26 | Sale | 99.0 | $510.02 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-05-26 | Sale | 7,506.0 | $509.34 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-05-26 | Sale | 3,886.0 | $508.53 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-05-26 | Sale | 6,879.0 | $507.34 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-05-22 | Sale | 13,000.0 | $515.6 |
| GOLDSTEIN JOSEPH L | Director | 2015-05-22 | Sale | 2,000.0 | $514.81 |
| GOLDSTEIN JOSEPH L | Director | 2015-05-22 | Sale | 2,000.0 | $513.74 |
| BROWN MICHAEL S | Director | 2015-05-15 | Sale | 5,000.0 | $495.0 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 200.0 | $457.21 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 700.0 | $456.36 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 1,536.0 | $455.48 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 1,999.0 | $454.38 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 265.0 | $453.71 |
| BAKER CHARLES A | Director | 2015-03-25 | Sale | 300.0 | $452.45 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 100.0 | $482.56 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 1,100.0 | $481.59 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 800.0 | $480.7 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 500.0 | $479.39 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 530.0 | $478.46 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 573.0 | $477.59 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 740.0 | $476.53 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 200.0 | $475.83 |